![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||
Copyright © 2006 by the Genetics Society of America Searching for Neuronal Left/Right Asymmetry: Genomewide Analysis of Nematode Receptor-Type Guanylyl Cyclases *Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032, †Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Center for Computational Biology and Bioinformatics, Columbia University Medical Center, New York, New York 10032 and ‡Institute of Neuroscience, University of Oregon, Eugene, Oregon 97403 1Corresponding author: Columbia University, 701 W. 68th St., HHSC 724, New York, NY. E-mail: or38/at/columbia.eduCommunicating editor: K. Kemphues Received January 12, 2006; Accepted March 3, 2006. This article has been cited by other articles in PMC.Abstract Functional left/right asymmetry (“laterality”) is a fundamental feature of many nervous systems, but only very few molecular correlates to functional laterality are known. At least two classes of chemosensory neurons in the nematode Caenorhabditis elegans are functionally lateralized. The gustatory neurons ASE left (ASEL) and ASE right (ASER) are two bilaterally symmetric neurons that sense distinct chemosensory cues and express a distinct set of four known chemoreceptors of the guanylyl cyclase (gcy) gene family. To examine the extent of lateralization of gcy gene expression patterns in the ASE neurons, we have undertaken a genomewide analysis of all gcy genes. We report the existence of a total of 27 gcy genes encoding receptor-type guanylyl cyclases and of 7 gcy genes encoding soluble guanylyl cyclases in the complete genome sequence of C. elegans. We describe the expression pattern of all previously uncharacterized receptor-type guanylyl cyclases and find them to be highly biased but not exclusively restricted to the nervous system. We find that >41% (11/27) of all receptor-type guanylyl cyclases are expressed in the ASE gustatory neurons and that one-third of all gcy genes (9/27) are expressed in a lateral, left/right asymmetric manner in the ASE neurons. The expression of all laterally expressed gcy genes is under the control of a gene regulatory network composed of several transcription factors and miRNAs. The complement of gcy genes in the related nematode C. briggsae differs from C. elegans as evidenced by differences in chromosomal localization, number of gcy genes, and expression patterns. Differences in gcy expression patterns in the ASE neurons of C. briggsae arise from a difference in cis-regulatory elements and trans-acting factors that control ASE laterality. In sum, our results indicate the existence of a surprising multitude of putative chemoreceptors in the gustatory ASE neurons and suggest the existence of a substantial degree of laterality in gustatory signaling mechanisms in nematodes. THE diversification of neuronal fate and function across the left/right axis of nervous systems is poorly understood but represents a fundamental problem in the neurosciences. This problem is well illustrated by a cursory comparison of structure and function of nervous systems. While the organization of nervous systems is largely bilaterally symmetric on a morphological level, brain functions are often highly lateralized (Hugdahl and Davidson 2003). Functional lateralization is presumably brought about by the diversification of neuronal function on a subanatomical level, such as differential gene expression in bilaterally symmetric structures. Indeed, quantitative comparison of transcript levels has recently revealed left/right asymmetries in gene expression profiles in the human brain (Sun et al. 2005). The nematode Caenorhabditis elegans provides a simple model organism to study the lateralization of nervous system function (Hobert et al. 2002). Such lateralization can be observed in the chemosensory system of the nematode. The best-studied chemosensory neurons are a group of 12 classes of neurons called the amphid sensory neurons (Figure 1A
To further analyze the extent of lateralization of the ASE gustatory neurons, we identified the complete set of guanylyl cyclase (gcy) genes in the C. elegans genome and undertook a genomewide analysis of their expression patterns. Previous counts of C. elegans receptor-type guanylyl cyclases were preliminary, given the incomplete nature of the C. elegans genome-sequencing project, but estimated to be in the higher twenties (Yu et al. 1997; Birnby et al. 2000). Expression patterns had been determined for eight receptor-type guanylyl cyclases (Yu et al. 1997; Birnby et al. 2000; L'Etoile and Bargmann 2000). We now report the final count of receptor-type guanylyl cyclases in the complete C. elegans genome to be 27. We present a comparative sequence analysis of all gcy genes and describe the expression patterns of all previously uncharacterized receptor-type guanylyl cyclases using gfp reporter gene fusions. We analyze the mechanisms of the regulation of gcy gene expression in the context of the ASE gustatory neurons, investigate the consequence of removing one ASE-expressed gcy gene on ASE neuron function, and examine the evolutionary divergence of gcy gene structure and expression. MATERIALS AND METHODS Strains and transgenes: The following wild-type and mutant strains were used: N2 wild-type Bristol isolate; Caenorhabditis briggsae AF16 wild-type strain; OH4349 lsy-6(ot71)dpy-11(e224); OH110 lim-6(nr2073) (Hobert et al. 1999); RB1000 gcy-5(ok921), 4× outcrossed; RB1010 gcy-5(ok930), 4× outcrossed; and OH2957 gcy-5(tm897), not outcrossed. The following transgenes were used: otIs3: Is[gcy-7prom gfp; lin-15(+)] (Chang et al. 2003), expressed in ASEL and the excretory canal cell; otIs151: Is[ceh-36prom dsRed2; rol-6(d)] (Johnston and Hobert 2003), expressed in ASEL/R and AWCL/R; otIs133: Is[ttx-3promB rfp; pNC4.2(unc-4(+)] (Wenick and Hobert 2004), expressed in AIYL/R; oyIs17: Is[gcy-8prom gfp; lin-15(+)], expressed in AFDL/R; and oyIs51: Is[srh-142prom rfp; lin-15(+)], expressed in ADFL/R, both gifts from Piali Sengupta.Sequence analysis: To identify GCY sequences, the sets of predicted proteins for C. elegans and C. briggsae were obtained from the Sanger Institute (http://www.sanger.ac.uk/Projects/C_elegans/WORMBASE/current/wormpep_download.shtml and ftp://ftp.sanger.ac.uk/pub/wormbase/cbriggsae/cb25.agp8/). Representative GCYs were used as position-specific iterated basic local alignment search tool (PSI-BLAST) queries to search the two proteomes. The HMMER 2.3.2 package (Eddy 1998) was used to construct a hidden Markov model from an alignment of GCY catalytic domains and to search for additional GCYs. The intracellular regions of the transmembrane GCYs and the complete soluble GCY sequences were aligned with T-coffee version 2.03 (Notredame et al. 2000). Maximum parsimony phylogenetic trees were found via heuristic search with PAUP* version 4.0 beta 10 (Swofford 2003). The trees were generated in 100 repeated searches with random addition of taxa to obtain the starting tree. Robustness of the tree partitions was evaluated by constructing a bootstrap consensus tree with 1000 replicates. The trees were visualized with TreeView version 1.6.6 (Page 1996). Nomenclature of gcy genes and gcy gene predictions: Most but not all gcy names were previously assigned (http://www.wormbase.org). We named two previously unnamed gcy genes gcy-28 (T01A4.1) and gcy-29 (C04H5.3). Both code for receptor-type proteins. A few gcy genes have been double named in the past. The most current names are (with old names in parentheses): gcy-18 (gcy-26), gcy-20 (gcy-16), gcy-17 (gcy-24), odr-1 (gcy-10), gcy-28 (gcy-38 in WS149), gcy-29 (gcy-39 in WS149). Since we detected several cases where individual parts of one C. elegans gene are homologous to separate, adjacent predicted C. briggsae genes (gene prediction in Wormbase WS149), we suspected that C. briggsae genes may have been incorrectly predicted. We therefore ran the FGENESH program at http://www.softberry.com (Salamov and Solovyev 2000) on chromosomal regions that contained the following predicted C. briggsae genes (from WS149): CBG07423(CBP15915) + CBG07424(CBP15916) + CBG07425(CBP15917), CBG20867(CBP04902) + CBG20868(CBP04903), and CBG19454(CBP11205) + CBG19453(CBP11204). In each of these three cases, we found that FGENESH predicted only one gene, whose product was homologous over its entire length with putative C. elegans orthologs. However, in two cases, the revised gene prediction overlooked exons predicted in the original prediction, which contained homology to GCY proteins. We therefore assembled alternate gene prediction by hand, on the basis of the similarity to known GCY proteins. We named these revised predictions CBP15915*, CBP04902*, and CBP11205* (see supplemental Figures 1 and 2 at http://www.genetics.org/supplemental/). On the basis of primary sequence homology, we also suspect that one of the two C. briggsae orthologs of C. elegans, gcy-35, has been incorrectly predicted as the two separate genes CBG20390 (CBP04780) and CBG20392 (CBP04781). Similarly, CBG10472 (CBP08561) and CBG10474 (CBP08562) likely constitute one gene. However, neither of these two suspicions could be corroborated by FGENESH. Generation of gfp reporter gene fusions, transgenic animals, and identification of reporter gene expressing cells: Most reporter genes were created by PCR fusion (Hobert 2002) and some were generated by subcloning PCR amplicons into pPD95.75 (see Table 1). Primer sequences and resulting transgenic arrays are shown in Table 1. DNA was injected at ~10–50 ng/μl using either unc-122 gfp or rol-6 as injection marker. Cell identifications were done on the basis of overall cell position and morphology and was significantly aided by the uses of the following four colabeling procedures.
Chemotaxis assays: Radial population chemotaxis assays were done as previously described (Chang et al. 2004). Assay plates were 10-cm tissue culture dishes containing 20 g/liter agar, 5 mm potassium phosphate (pH 6.0), 1 mm CaCl2, and 1 mm MgSO4. To set up the chemical gradients on the assay plates, a 10-μl drop of attractant was placed 15 mm from the edge of the plate at the “attractive spot.” A 10-μl drop of ddH20 was placed diametrically opposite and was considered the “negative control spot.” The attractant was allowed to diffuse for 14–16 hr at room temperature. To increase the steepness of the chemical gradient, 4–4.5 hr prior to chemotaxis assay, 4 μl of attractant was added to the “attractive spot” and 4 μl of ddH20 was added to the “negative control spot.” The attractants NaCl and NH4Cl (Sigma, St. Louis) were dissolved in ddH2O to a concentration of 2.5 m and were adjusted to pH 6.0 with either NH4OH or acetic acid. Worms were washed three times in sterile water to remove food and salts. Worms were then placed at the center of the plate and allowed to chemotax for 1 hr. Worms reaching either the attractant peak or the negative control spot (sterile water) were immobilized with sodium azide. Results were quantified by counting worms that were located at (A) the attractant, (B) the center of the plate, or (C) the negative control. Since animals carrying two of the three gcy-5 knockout alleles (ok921 and ok930) did not disperse well from the center of the plate, we calculated a modified chemotaxis index, defined as C.I. = A/(A + C). This index therefore disregards worms that do not reach either the attractant or the negative control spot. It is doubtful that the dispersion defects of ok921 and ok930 alleles are significant since the putative null allele tm897 does not show these defects. RESULTS Identification of the complete set of GCY proteins in C. elegans: To identify the complete set of guanylyl cyclases in C. elegans, we employed PSI-BLAST to search the latest release of the complete C. elegans genome databases, using a set of known GCY proteins as queries. We identified a total of 34 predicted GCY proteins, several more than reported in previous searches of incomplete genome sequence databases (Yu et al. 1997; Bargmann 1998; Birnby et al. 2000). The identified GCY proteins fall into two distinct families, receptor-type guanylyl cyclases (encoded by 27 genes; henceforth called receptor-type gcy genes) and soluble cyclases (encoded by 7 genes; henceforth called soluble gcy genes). Both families contain a guanylyl cyclase catalytic domain (Figure 2
The overall domain topology of C. elegans GCY proteins is similar to that of mammalian GCY proteins. Multiple transmembrane-containing GCY proteins, which can be found in unicellular eukaryotes (Wedel and Garbers 2001), are not present in C. elegans. GCY-27 is an unusual receptor-type GCY protein (Figure 2
We analyzed the relatedness of soluble and receptor-type GCY proteins in more detail by generating a maximum-parsimony bootstrap tree using the intracellular domain of the receptor-type GCYs and the complete sequences of the soluble GCYs. The soluble GCYs branch separately from the transmembrane-type proteins and are clustered into two subgroups. Many receptor-type GCY proteins also fall into small and well-defined subgroups (Figure 3A Notably, in a substantial number of cases, the degree of sequence relation correlates with proximity in the genome sequence (Figure 3B Expression patterns of receptor-type gcy genes: While the expression of all seven soluble gcy genes has already been described (Yu et al. 1997; Cheung et al. 2004; Gray et al. 2004), the expression patterns of only 8 of the 27 receptor-type gcy genes was previously reported, 6 in the context of a preliminary and incomplete genome analysis (gcy-5, gcy-6, gcy-7, gcy-8, gcy-10/odr-1, gcy-12, and gcy-22) and 2 in the course of a functional analysis (odr-1 and daf-11) (Yu et al. 1997; Birnby et al. 2000; L'Etoile and Bargmann 2000; Johnston et al. 2005) (summarized in Table 2). We generated gfp reporter fusions to the putative cis-regulatory regions of the remaining 19 gcy genes (schematically shown in Figure 4
Broad vs. cell type specific: Cell types: The expression of receptor-type gcy genes is strongly biased toward the nervous system. With the exception of two non-neuronally expressed gcy genes (gcy-9 and gcy-11), all gcy genes are expressed in a restricted subset of neurons. Of 27 genes, 21 are exclusively expressed in the nervous system and 4 are expressed in restricted sets of both neuronal and non-neuronal cells (Table 2; Figure 5 Expression within the nervous system: Within the nervous system, most but not all, C. elegans gcy genes are expressed in sensory neurons. All except two pairs (ASH and ADF) of the 12 amphid sensory neuron classes shown in Figure 1A
Coexpression: A notable general feature of C. elegans gcy gene expression profiles, both receptor and non-receptor type, is that a small number of neuron classes coexpress a substantial number of gcy genes (Figure 5
Left/right asymmetric expression: Two previous studies identified a total of four left/right asymmetrically expressed gcy genes in the ASE gustatory neuron class (gcy-5, gcy-6, gcy-7, and gcy-22; Table 2) (Yu et al. 1997; Johnston et al. 2005). We have identified five more gcy genes that are expressed in a left/right asymmetric manner in the ASE neuron class. gcy-1, gcy-3, and gcy-4 are expressed predominantly or exclusively in ASER, while gcy-14 and gcy-20 are expressed predominantly or exclusively in ASEL (Figure 5
gcy genes that are asymmetrically expressed in either ASER or ASEL are not asymmetrically expressed in other sensory neurons. For example, the gcy-1 and gcy-3 genes, two ASER-expressed genes, are expressed bilaterally in other pairs of neurons. In addition to the asymmetrically expressed gcy genes, we found two bilaterally, albeit weakly, expressed gcy genes in ASEL/R, gcy-19 and gcy-29, increasing the percentage of ASE-expressed gcy genes to 41% (11/27) of all gcy genes. The possible lack of regulatory elements in gfp reporter genes may lead to the oversight of perhaps even more ASE-expressed gcy genes. We have not observed any other obvious left/right asymmetric gcy gene patterns in bilaterally symmetric neurons, including the AWCL/R neurons (which we could easily identify with the DsRed2-expressing otIs151 transgene). The AWCL/R neurons are the only other known neuron pair displaying functional laterality (Wes and Bargmann 2001) and although they express five gcy genes (Table 4), none of them is obviously lateralized. Similarity of chromosomal position, primary sequence, and gene expression patterns: Strikingly, the coexpression of gcy genes in ASEL or ASER correlates extensively with the primary sequence similarity and chromosomal location of the gcy genes. The ASER-expressed gcy-1, gcy-3, gcy-4, and gcy-5 genes fall into one sequence subgroup (Figure 3A Similarly, all four ASEL-expressed gcy genes (gcy-6, gcy-7, gcy-14, gcy-20) fall into one sequence subgroup (Figure 3A A similar correlation of sequence relation and gene expression can also be observed in non-ASE-expressed gcy genes. The gcy-8, gcy-18, and gcy-23 genes are related by sequence (Figure 3A Taken together, all these similarities indicate that related gcy genes arose by local gene duplication events that duplicated not only the protein-coding region but also their cis-regulatory control regions. Regulation of left/right asymmetric expression of gcy genes: How is the laterality of the newly characterized ASEL/R-expressed gcy genes controlled? We have previously identified a complex network of transcription factors and microRNAs (miRNAs) that control ASE laterality after animals have passed through an initial hybrid precursor state (Chang et al. 2003, 2004; Johnston and Hobert 2003, 2005; Johnston et al. 2005). These regulatory factors fall into two broad categories: (1) factors that control the activity of a bistable feedback loop that determines whether an ASE neuron adopts the ASEL or ASER state and (2) factors that act outside the regulatory loop to determine specific subsets of terminal differentiation features. To test whether the newly identified, asymmetrically expressed gcy genes are subject to regulation by this network or controlled by a different set of regulatory factors, we analyzed gfp reporter expression profiles in two null mutant backgrounds that are representative for each category, lsy-6 and lim-6. Animals that lack the lsy-6 miRNA display a complete switch from the ASEL fate to the ASER fate (Johnston and Hobert 2003) and animals that lack the lim-6 LIM homeobox gene fail to activate a defined subset of ASEL features and fail to repress a subset of ASER features (Hobert et al. 1999; Johnston et al. 2005). We find that all newly identified gcy genes are components of the ASEL and ASER state that is controlled by the lsy-6-dependent regulatory feedback loop. The ASER-specific gcy genes are ectopically activated in ASEL upon loss of the ASEL inducer lsy-6, and the ASEL-specific gcy genes are lost in the ASEL neuron of lsy-6 null mutant animals (Figure 6 How does the lim-6 LIM homeobox gene contribute to the expression of the newly identified gcy genes? Similarly to the previously described ASEL-specific gcy-6 and gcy-7 genes, we found that the ASEL bias of gcy-14 and gcy-20 are unaffected by loss of lim-6 (Figure 6B Functional analysis of gcy-5: Three putative loss-of-function alleles have been generated by the C. elegans knockout consortia in one of the nine asymmetrically expressed gcy genes, gcy-5 (Figure 7A
Guanylyl cyclase genes in the nematode C. briggsae: The availability of the genome sequence of the nematode C. briggsae, which diverged ~100 million years ago (Stein et al. 2003), provided us with the opportunity to examine the evolution of the gcy gene family. To identify the complete set of guanylyl cyclase genes in C. briggsae, we again employed PSI-BLAST to search the latest release of the complete genome databases of C. briggsae, using a set of known GCY proteins as queries. We identified a total of 33 gcy genes in C. briggsae, one less than in C. elegans (Figure 3A We have mentioned above the existence of a receptor-type GCY protein, GCY-27, that lacks a predicted extracellular domain. C. elegans GCY-27 is closely related to the intracellular domain of the receptor-type ODR-1; both proteins are more closely related to each other than to the two closest C. briggsae homologs (Figure 3A We sought to investigate the issue of orthology and paralogy in more detail by (a) analyzing the degree of synteny among gcy genes and (b) by determining the expression patterns of some orthologous C. briggsae genes. For the syteny analysis, we focused on one subgroup of left/right asymmetrically expressed gcy subfamilies, the “gcy-5 subfamily” (Figure 3A We found that the chromosomal arrangement of members of the gcy-5 subfamily differ significantly between C. elegans and C. briggsae. The gcy-19 orthologs are located in distinct environments in C. elegans and C. briggsae (Figure 8A
Evolutionary divergence of left/right asymmetric gcy gene expression patterns: Using gfp reporter genes generated from genomic C. briggsae DNA, we analyzed the expression of five gcy genes in C. briggsae. We generated gfp fusions to the single C. briggsae ortholog of the C. elegans gcy-1, gcy-2, and gcy-3 genes and the C. briggsae orthologs of the C. elegans gcy-4, gcy-5, gcy-7, and gcy-19 genes. We observed no significant adult expression for C. briggsae gcy-1/2/3 prom gfp, C. briggsae gcy-5prom gfp, and C. briggsae gcy-7prom gfp in several transgenic C. briggsae lines, which is possibly due to the limited size of the reporter gene constructs (due to the size of the intergenic regions, none of the reporter constructs extended to the previous gene; data not shown). We did, however, observe interesting expression patterns for C. briggsae gcy-4prom gfp and C. briggsae gcy-19prom gfp and focused our analysis on these genes.We found that C. briggsae gcy-4prom gfp is expressed bilaterally in both ASEL and ASER (Figure 9A gfp, whose expression is biased to ASER in C. elegans (Figure 5C gfp construct into C. elegans. If the C. elegans and C. briggsae gcy-4 reporter constructs contained the same cis-regulatory information, C. briggsae gcy-4prom gfp should be expressed in the same pattern in C. briggsae and C. elegans (bilateral expression in ASEL and ASER). In contrast, if there are differences in trans-acting factors, then the C. briggsae gcy-4prom gfp reporter should be expressed in C. elegans in a manner similar to that of C.elegans gcy-4prom gfp (biased to ASER). We found that C. briggsae gcy-4prom gfp expression becomes ASER biased when injected into C. elegans, which mimics the expression of C. elegans gcy-4prom gfp (Figure 9A
The gcy-19 locus represents another example of evolutionary divergence of left/right asymmetric gene expression. C. elegans gcy-19prom gfp is strongly expressed in the IL2 sensory neurons and weakly expressed in both ASEL and ASER and in several other head sensory neurons in C. elegans (Figure 5N gfp shows strong and exclusive expression in the C. briggsae ASER neuron, but not in any other head neurons (Figure 9B gfp reporter is still expressed exclusively in ASER (Figure 9BDISCUSSION Biochemical properties and functions of receptor-type guanylyl cyclases have been summarized and discussed in several reviews over the past few years (Lucas et al. 2000; Wedel and Garbers 2001; Morton 2004). Recent findings on the function of soluble gcy genes in oxygen sensation (Cheung et al. 2004, 2005; Gray et al. 2004) have also been reviewed (Rankin 2005). We focus here on several specific outcomes of our studies. The function of nematode receptor-type gcy genes: C. elegans and C. briggsae contain an unusual number of receptor-type gcy genes. Insects such as Drosophila melanogaster or Anopheles gambiae contain six receptor-type guanylyl cyclases (Morton 2004), mammals contain seven (four orphan and three peptide-binding receptors) (Lucas et al. 2000; Wedel and Garbers 2001), but C. elegans contains 27 and C. briggsae 25 (this study). The physiological function of insect gcy genes is entirely unknown, although the expression of the only two analyzed receptors in sensory neurons (among other neurons) has been noted (Morton 2004). Vertebrate gcy genes are expressed in several different tissue types, including chemosensory neurons (Wedel and Garbers 2001). We propose that the significant expansion of receptor-type gcy genes in the nematode lineage is a reflection of their employment as chemoreceptors used to assess and navigate through their natural habitat. This hypothesis, which was also put forward by Yu et al. (1997), is mainly based on the observation that almost 90% (24/27) of gcy genes are expressed in sensory neurons (lack of sensory neuron expression of three gcy genes may be caused merely by a lack of the complete set of cis-regulatory elements in the reporter genes used). Moreover, 41% (11/27) of gcy genes are expressed in the main gustatory neuron class of C. elegans, ASE. This neuron class has previously been shown to be functionally lateralized in that it can sense different chemosensory cues (Pierce-Shimomura et al. 2001). Consistent with a role of gcy genes as chemoreceptors, we find that 9/11 ASE-expressed gcy genes are expressed in a left/right asymmetric manner, thereby providing molecular correlates to functional lateralization. Amino acids are among the several classes of chemicals that can be sensed by the ASE neurons (Bargmann and Horvitz 1991). The presence of a domain in the extracellular parts of many GCY proteins that is homologous to bacterial amino-acid-binding proteins, the RFLBR domain, makes receptor-type GCY proteins good candidates for amino acid receptors. More sensitive assays (Wicks et al. 2000; Faumont et al. 2005; Miller et al. 2005; Faumont and Lockery 2006) than those used in the initial large scale survey of chemosensory cues (Ward 1973) will be required to establish the full spectrum of amino acids and other possible sensory cues that signal through ASE. Such a systematic cataloging of sensory cues needs to be followed by a systematic analysis of strains harboring deletions in gcy genes or misexpressing gcy genes to establish their roles as amino acid receptors. A role for GCY proteins as salt receptors is also conceivable but highly speculative at present. There is as yet no consensus about the molecular identity of salt receptors in the vertebrate gustatory system. Notably, the crystal structure of the ANP receptor, a mammalian GCY protein that, like most C. elegans GCY proteins, contains an extracellular RFLBR domain, revealed a high-affinity chloride-binding site (van den Akker et al. 2000). Our attempt to establish a mutant phenotype for a gcy gene, the ASER-expressed gcy-5 gene, has failed so far, but we note that we have tested only one of the two known cues sensed in an ASER-specific manner, namely chloride ions. The failure to detect a mutant phenotype, however, does allow the conclusion that gcy genes such as gcy-5 are unlikely to control a fundamental, nonredundant aspect of the development or overall function of the neuron. It appears more likely that gcy-5 and, by inference, other ASE-expressed gcy genes fulfill a sensory-modality-specific function in ASE, such as being a receptor for a specific class of gustatory cues. Whereas more than half of C. elegans gcy genes (15/27) are expressed exclusively in sensory neurons, one-third are also expressed in nonsensory neurons, including interneurons and non-neuronal cells, suggesting that GCY proteins also respond to endogenously produced ligands. Since all known ligands for mammalian GCY proteins are peptidergic-signaling molecules (Lucas et al. 2000) and since C. elegans contains scores of neuropeptide-encoding genes (Li et al. 1999), we propose that nonsensory C. elegans GCY proteins may be receptors for peptidergic ligands. The function of receptor-type GCY proteins may not be restricted to a receptor function. The C. elegans ODR-1 protein does not require its extracellular domain to fulfill its function in transducing odorsensory signals (L'Etoile and Bargmann 2000). Moreover, one GCY protein that we describe here, the ODR-1-related GCY-27 protein, entirely lacks an extracellular domain. These proteins may heterodimerize with ligand-binding GCY receptors to constitute a receptor complex and/or they may serve as second-messenger-producing signaling proteins that are embedded in signal transduction cascades triggered by other receptor systems. Coexpression of gcy genes: Another notable feature of gcy gene expression patterns is their degree of coexpression. Six gcy genes are coexpressed in the ASI sensory neuron class, five are coexpressed in ASER, four in ASEL, five in the AWC olfactory neuron class, four in the AFD thermosensory neuron class, and two gcy genes are each coexpressed in the ASG and PHA phasmid sensory neuron classes. In addition, several gcy genes expressed in multiple cell types show similar and nonintuitive combinations of expression patterns. gcy-7 and gcy-20 are coexpressed in ASEL and the excretory cell (two cells of no obvious relation) and daf-11 and odr-1 show a precisely overlapping expression pattern in five amphid sensory neurons (Birnby et al. 2000; L'Etoile and Bargmann 2000). Coexpression of receptor-type GCY proteins raises at least two different possibilities:
Laterality in the nematode nervous system: With the identification of a total of nine asymmetrically expressed gcy genes, the ASE neurons present so far the most striking example of a lateralized chemosensory neuron class. As mentioned above, previous work has provided a conceptual framework for the functional relevance of laterality in the ASE neurons (Pierce-Shimomura et al. 2001). We expect that other neuron classes may similarly employ the principle of lateralizing chemosensory function. However, our expression analysis has not revealed further examples of laterality in gcy gene expression profiles in other bilaterally symmetric amphid neurons, thereby leaving only the AWC odorsensory and ASE gustatory neurons as neuron pairs with lateralized functions (Figure 1B Our analysis of the laterality of gcy gene expression in C. briggsae revealed several striking examples of evolutionary plasticity in the laterality of the gustatory system of nematodes. The variation that we observe appears to be caused by a variation in both cis-acting elements and trans-acting factors, a conclusion that we can draw from our comparison of C. briggsae gcy promoter activity in C. briggsae and C. elegans. Variations in cis-regulatory control have been recognized as a major feature of evolutionary processes (Carroll et al. 2001) but our cross-species analysis also provides strong support for the more conventional view of the evolution of trans-acting factors. The clearly distinct nature of cis-regulatory architecture of at least some gcy genes in C. elegans and C. briggsae is a strong reminder that the use of bioinformatic tools that use phylogenetic conservation to identify cis-regulatory elements in genomic sequences (e.g., Bigelow et al. 2004; for review see Bulyk 2003) may easily lead to false-negative predictions. It is difficult at this point to speculate about differences in the trans-acting factors that control laterality in C. elegans and C. briggsae. We have demonstrated that so far all known left/right asymmetrically expressed terminal differentiation markers in the ASEL/R neurons, including all gcy genes, are under control of a previously described bistable feedback loop that is composed of several transcription factors and miRNAs (Johnston et al. 2005). The activity of transcription factors that are controlled by the output of the loop, for example, the lim-6 LIM homeobox gene (Figure 6B Mutant screening approaches that identify the complete set of trans-acting factors controlling left/right asymmetric gcy gene expression in C. elegans and experimental promoter dissection approaches that identify cis-regulatory elements through which these trans-acting factors act are currently ongoing in our laboratory and are likely to reveal the molecular control of laterality in the gustatory system of C. elegans and its divergence in C. briggsae. Acknowledgments We thank Qi Chen for expert technical assistance; the C. elegans gene knockout consortia at Tokyo Women's Medical University School of Medicine (led by Shohei Mitani) and at the Oklahoma Medical Research Foundation (led by Bob Barstead) for providing mutant strains; the Caenorhabditis Genetics Center (CGC) and members of the worm community for providing strains; Piali Sengupta for help with cell identifications; and members of the Hobert lab and Cori Bargmann for comments on the manuscript. This work was supported by the National Institutes of Health (NIH) Medical Scientist Training Program (to C.O.O.), NIH R01 NS050266-01 (O.H.), and NIH R01 NS39996-05 (O.H.). B.H. and O.H. are Investigators of the Howard Hughes Medical Institute. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||
Science. 2005 Jun 17; 308(5729):1794-8.
[Science. 2005]Nat Rev Neurosci. 2002 Aug; 3(8):629-40.
[Nat Rev Neurosci. 2002]Nature. 2001 Apr 5; 410(6829):694-8.
[Nature. 2001]Nature. 2001 Apr 5; 410(6829):698-701.
[Nature. 2001]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Cell. 1999 Nov 12; 99(4):387-98.
[Cell. 1999]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Development. 1999 Apr; 126(7):1547-62.
[Development. 1999]Genes Dev. 2003 Sep 1; 17(17):2123-37.
[Genes Dev. 2003]Nature. 2003 Dec 18; 426(6968):845-9.
[Nature. 2003]Dev Cell. 2004 Jun; 6(6):757-70.
[Dev Cell. 2004]Bioinformatics. 1998; 14(9):755-63.
[Bioinformatics. 1998]J Mol Biol. 2000 Sep 8; 302(1):205-17.
[J Mol Biol. 2000]Comput Appl Biosci. 1996 Aug; 12(4):357-8.
[Comput Appl Biosci. 1996]Genome Res. 2000 Apr; 10(4):516-22.
[Genome Res. 2000]Biotechniques. 2002 Apr; 32(4):728-30.
[Biotechniques. 2002]J Neurosci. 2004 Mar 3; 24(9):2191-201.
[J Neurosci. 2004]Dev Biol. 1985 Sep; 111(1):158-70.
[Dev Biol. 1985]J Neurosci. 2004 Mar 3; 24(9):2191-201.
[J Neurosci. 2004]Dev Biol. 1985 Sep; 111(1):158-70.
[Dev Biol. 1985]Nature. 2004 Aug 12; 430(7001):785-9.
[Nature. 2004]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Science. 1998 Dec 11; 282(5396):2028-33.
[Science. 1998]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]J Biol Chem. 1997 May 9; 272(19):12342-9.
[J Biol Chem. 1997]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Annu Rev Physiol. 2001; 63():215-33.
[Annu Rev Physiol. 2001]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Curr Biol. 2004 Jun 22; 14(12):1105-11.
[Curr Biol. 2004]Nature. 2004 Jul 15; 430(6997):317-22.
[Nature. 2004]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Annu Rev Physiol. 2001; 63():215-33.
[Annu Rev Physiol. 2001]Genetics. 2006 Apr; 172(4):2239-52.
[Genetics. 2006]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Curr Biol. 2004 Jun 22; 14(12):1105-11.
[Curr Biol. 2004]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]EMBO J. 1991 Dec; 10(12):3959-70.
[EMBO J. 1991]Nature. 2001 Apr 5; 410(6829):698-701.
[Nature. 2001]Genes Dev. 2003 Sep 1; 17(17):2123-37.
[Genes Dev. 2003]Nature. 2004 Aug 12; 430(7001):785-9.
[Nature. 2004]Nature. 2003 Dec 18; 426(6968):845-9.
[Nature. 2003]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Development. 1999 Apr; 126(7):1547-62.
[Development. 1999]Neuron. 1991 Nov; 7(5):729-42.
[Neuron. 1991]Nature. 2001 Apr 5; 410(6829):694-8.
[Nature. 2001]Nature. 2004 Aug 12; 430(7001):785-9.
[Nature. 2004]PLoS Biol. 2003 Nov; 1(2):E45.
[PLoS Biol. 2003]Pharmacol Rev. 2000 Sep; 52(3):375-414.
[Pharmacol Rev. 2000]Annu Rev Physiol. 2001; 63():215-33.
[Annu Rev Physiol. 2001]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Curr Biol. 2004 Jun 22; 14(12):1105-11.
[Curr Biol. 2004]Curr Biol. 2005 May 24; 15(10):905-17.
[Curr Biol. 2005]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Pharmacol Rev. 2000 Sep; 52(3):375-414.
[Pharmacol Rev. 2000]Annu Rev Physiol. 2001; 63():215-33.
[Annu Rev Physiol. 2001]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Nature. 2001 Apr 5; 410(6829):694-8.
[Nature. 2001]Neuron. 1991 Nov; 7(5):729-42.
[Neuron. 1991]Dev Biol. 2000 May 15; 221(2):295-307.
[Dev Biol. 2000]J Neurobiol. 2005 Nov; 65(2):171-8.
[J Neurobiol. 2005]J Neurosci. 2005 Mar 30; 25(13):3369-78.
[J Neurosci. 2005]J Neurophysiol. 2006 Mar; 95(3):1976-81.
[J Neurophysiol. 2006]Nature. 2000 Jul 6; 406(6791):101-4.
[Nature. 2000]Pharmacol Rev. 2000 Sep; 52(3):375-414.
[Pharmacol Rev. 2000]Ann N Y Acad Sci. 1999; 897():239-52.
[Ann N Y Acad Sci. 1999]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Mol Neurobiol. 2004 Apr; 29(2):97-116.
[Mol Neurobiol. 2004]Nature. 2001 Apr 5; 410(6829):694-8.
[Nature. 2001]Science. 1998 Dec 11; 282(5396):2028-33.
[Science. 1998]BMC Bioinformatics. 2004 Mar 12; 5():27.
[BMC Bioinformatics. 2004]Genome Biol. 2003; 5(1):201.
[Genome Biol. 2003]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Neuron. 1991 Nov; 7(5):729-42.
[Neuron. 1991]Neuroreport. 1999 Mar 17; 10(4):753-7.
[Neuroreport. 1999]Nature. 2001 Apr 5; 410(6829):694-8.
[Nature. 2001]Cell. 1999 Nov 12; 99(4):387-98.
[Cell. 1999]Nature. 2001 Apr 5; 410(6829):698-701.
[Nature. 2001]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Nature. 2004 Aug 12; 430(7001):785-9.
[Nature. 2004]Nat Rev Neurosci. 2002 Aug; 3(8):629-40.
[Nat Rev Neurosci. 2002]Genetics. 2000 May; 155(1):85-104.
[Genetics. 2000]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3384-7.
[Proc Natl Acad Sci U S A. 1997]Neuron. 2000 Mar; 25(3):575-86.
[Neuron. 2000]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12449-54.
[Proc Natl Acad Sci U S A. 2005]Genetics. 2006 Apr; 172(4):2239-52.
[Genetics. 2006]